Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution
 Back to Profile

Jessica J. Kandel

Concepts (400)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neovascularization, Pathologic
30
2015
337
3.230
 Why?
Wilms Tumor
18
2013
38
3.140
 Why?
Kidney Neoplasms
18
2016
584
2.130
 Why?
Endothelial Growth Factors
14
2009
54
1.710
 Why?
Lymphokines
11
2003
75
1.500
 Why?
Lymphatic Abnormalities
4
2016
8
1.480
 Why?
Pediatrics
4
2019
332
1.440
 Why?
Vascular Endothelial Growth Factor A
23
2012
373
1.370
 Why?
Receptors, Notch
4
2018
116
1.220
 Why?
Angiogenesis Inhibitors
15
2012
289
1.220
 Why?
Specialties, Surgical
2
2019
59
1.190
 Why?
Mice, Nude
30
2015
764
1.000
 Why?
Neuroblastoma
11
2020
348
0.970
 Why?
Vascular Endothelial Growth Factors
13
2004
56
0.820
 Why?
Hemolysin Proteins
1
2018
33
0.730
 Why?
Human Umbilical Vein Endothelial Cells
1
2018
62
0.720
 Why?
Neoplasms
11
2013
2618
0.690
 Why?
Bacterial Toxins
1
2018
106
0.690
 Why?
Physicians
2
2022
588
0.650
 Why?
Antineoplastic Agents
6
2015
2269
0.640
 Why?
Antibodies, Monoclonal
10
2008
1367
0.640
 Why?
Topotecan
5
2004
46
0.610
 Why?
Child
18
2020
6481
0.600
 Why?
Mice
39
2020
10719
0.590
 Why?
Picibanil
1
2015
2
0.590
 Why?
Staphylococcus aureus
1
2018
249
0.590
 Why?
Lymphangioma
1
2015
15
0.580
 Why?
Sclerotherapy
1
2015
15
0.580
 Why?
Sarcoma, Ewing
3
2012
41
0.560
 Why?
Epithelial-Mesenchymal Transition
2
2012
61
0.560
 Why?
Laser Therapy
1
2015
140
0.510
 Why?
Humans
65
2022
79552
0.490
 Why?
Hospitals, Pediatric
1
2013
96
0.480
 Why?
Esophageal Atresia
1
2012
16
0.480
 Why?
Transcription Factors
3
2012
1464
0.470
 Why?
Transplantation, Heterologous
8
2009
352
0.470
 Why?
Pneumonia, Mycoplasma
1
2012
7
0.470
 Why?
Receptor, erbB-2
2
2003
182
0.460
 Why?
Bacterial Proteins
1
2018
828
0.460
 Why?
Animals
44
2020
25615
0.460
 Why?
Esophagus
1
2012
101
0.460
 Why?
Hemangioma
3
2012
55
0.450
 Why?
Recombinant Fusion Proteins
2
2004
555
0.450
 Why?
Tumor Cells, Cultured
14
2008
1039
0.440
 Why?
Neoplasm Transplantation
11
2004
387
0.440
 Why?
Signal Transduction
4
2018
3148
0.430
 Why?
Surgery, Computer-Assisted
1
2012
98
0.430
 Why?
Neoplasms, Experimental
4
2012
270
0.420
 Why?
Neoplasm Metastasis
3
2012
1032
0.410
 Why?
Quality of Health Care
1
2013
360
0.400
 Why?
Angiopoietin-1
1
2009
4
0.370
 Why?
Receptor, TIE-2
1
2009
14
0.370
 Why?
Immunohistochemistry
12
2013
1722
0.370
 Why?
Cell Line, Tumor
11
2020
2322
0.360
 Why?
Endothelium, Vascular
8
2009
428
0.360
 Why?
Brain Ischemia
1
2012
311
0.350
 Why?
Xenograft Model Antitumor Assays
8
2020
442
0.340
 Why?
Microbubbles
3
2020
34
0.340
 Why?
Ovarian Diseases
1
2007
32
0.340
 Why?
Pelvic Neoplasms
1
2007
42
0.330
 Why?
Receptors, Vascular Endothelial Growth Factor
2
2004
58
0.330
 Why?
Neoplasm Proteins
4
2004
528
0.330
 Why?
Ovary
1
2007
242
0.310
 Why?
Radiation Injuries
1
2007
158
0.300
 Why?
Female
34
2018
42249
0.290
 Why?
Propranolol
2
2016
46
0.280
 Why?
In Situ Nick-End Labeling
6
2004
121
0.280
 Why?
Intercellular Signaling Peptides and Proteins
3
2008
176
0.270
 Why?
Stroke
1
2012
752
0.270
 Why?
In Situ Hybridization
5
2004
305
0.260
 Why?
Infant
9
2018
2924
0.260
 Why?
Contrast Media
4
2020
1008
0.260
 Why?
Liver Neoplasms
4
2015
620
0.240
 Why?
Infant, Newborn
8
2016
2250
0.230
 Why?
Rhabdoid Tumor
1
2002
19
0.230
 Why?
Perfusion Imaging
2
2020
43
0.230
 Why?
Efficiency
1
2022
37
0.220
 Why?
Benchmarking
1
2022
58
0.220
 Why?
Receptor, Notch1
2
2015
80
0.220
 Why?
Vascular Neoplasms
1
2001
18
0.220
 Why?
Vincristine
1
2001
106
0.220
 Why?
Mediastinal Neoplasms
1
2001
43
0.220
 Why?
Apoptosis
7
2020
1650
0.210
 Why?
Antibodies, Monoclonal, Humanized
6
2015
898
0.210
 Why?
Nephrectomy
2
2013
281
0.210
 Why?
Guilt
1
2020
9
0.210
 Why?
Social Responsibility
1
2020
53
0.200
 Why?
Surgery Department, Hospital
1
2020
40
0.200
 Why?
Triage
1
2020
97
0.200
 Why?
Gene Expression Regulation
1
2009
1880
0.200
 Why?
Ultrasonography, Interventional
1
2020
106
0.200
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2011
869
0.190
 Why?
Doxorubicin
1
2020
277
0.190
 Why?
Tumor Suppressor Protein p53
1
2002
359
0.190
 Why?
Antineoplastic Agents, Phytogenic
1
2001
284
0.190
 Why?
DNA-Binding Proteins
2
2018
1181
0.190
 Why?
Infection Control
1
2020
104
0.180
 Why?
Operating Rooms
1
2020
118
0.180
 Why?
Diatrizoate Meglumine
1
2018
23
0.180
 Why?
Lung Neoplasms
6
2003
2112
0.180
 Why?
Nuclear Proteins
1
2003
679
0.180
 Why?
Tissue Adhesions
1
2018
48
0.180
 Why?
Neoplasm Recurrence, Local
2
2005
1166
0.180
 Why?
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
1
2018
48
0.180
 Why?
Amyloid Precursor Protein Secretases
1
2018
87
0.180
 Why?
Intestinal Obstruction
1
2018
90
0.170
 Why?
Antineoplastic Combined Chemotherapy Protocols
3
2004
2277
0.170
 Why?
Fluorescent Antibody Technique, Indirect
2
2009
67
0.160
 Why?
Child, Preschool
7
2018
3544
0.160
 Why?
Treatment Outcome
7
2016
7470
0.160
 Why?
Staphylococcal Infections
1
2018
237
0.150
 Why?
Patient Selection
1
2020
662
0.150
 Why?
Cell Division
5
2009
703
0.150
 Why?
Epidermolysis Bullosa Dystrophica
1
2015
1
0.150
 Why?
Capillaries
2
2014
89
0.150
 Why?
Hemangiosarcoma
2
2006
17
0.150
 Why?
Contract Services
1
2015
5
0.140
 Why?
Surgicenters
1
2015
5
0.140
 Why?
Hepatoblastoma
3
2008
9
0.140
 Why?
Adrenergic beta-Antagonists
1
2016
158
0.140
 Why?
Anastomotic Leak
1
2016
101
0.140
 Why?
Anastomosis, Surgical
2
2016
286
0.140
 Why?
Skin Neoplasms
2
2012
510
0.140
 Why?
Port-Wine Stain
1
2014
2
0.140
 Why?
Coronavirus Infections
1
2020
283
0.140
 Why?
Combined Modality Therapy
2
2016
1602
0.140
 Why?
Pneumonia, Viral
1
2020
302
0.140
 Why?
Intraoperative Complications
2
2013
170
0.140
 Why?
Decision Making
1
2020
595
0.140
 Why?
Arteriovenous Malformations
1
2014
33
0.130
 Why?
Guideline Adherence
1
2016
215
0.130
 Why?
Microarray Analysis
2
2011
93
0.130
 Why?
Lymphatic Vessels
1
2015
66
0.130
 Why?
Personnel Staffing and Scheduling
1
2015
89
0.130
 Why?
Medical Audit
1
2013
40
0.130
 Why?
Quality Indicators, Health Care
1
2015
130
0.130
 Why?
Appendicitis
1
2014
54
0.130
 Why?
Gene Expression Regulation, Neoplastic
4
2018
1164
0.130
 Why?
Disease Models, Animal
6
2013
2179
0.120
 Why?
Membrane Proteins
2
2018
1161
0.120
 Why?
Neoplasm Seeding
1
2013
17
0.120
 Why?
Colon
1
2016
488
0.120
 Why?
Fibroblast Growth Factor 2
2
1999
56
0.120
 Why?
Transplantation Conditioning
1
2015
367
0.120
 Why?
Interdisciplinary Communication
1
2013
123
0.120
 Why?
History, 21st Century
1
2013
167
0.120
 Why?
Cooperative Behavior
1
2013
162
0.120
 Why?
Collagen Type XI
1
2011
1
0.120
 Why?
Cell Differentiation
2
2018
1419
0.120
 Why?
Tomography, Optical
1
2012
9
0.110
 Why?
History, 20th Century
1
2013
303
0.110
 Why?
Paraffin Embedding
2
2002
77
0.110
 Why?
Microscopy, Fluorescence
2
2004
420
0.110
 Why?
Polyethyleneimine
1
2011
7
0.110
 Why?
Brain Neoplasms
2
2012
701
0.110
 Why?
Heart Failure
2
2012
1075
0.110
 Why?
Maleimides
1
2011
29
0.110
 Why?
Observer Variation
1
2013
589
0.110
 Why?
Neoplasm Invasiveness
2
2011
513
0.110
 Why?
Digestive System Surgical Procedures
1
2012
118
0.110
 Why?
Cell Hypoxia
2
2009
160
0.110
 Why?
Fibrosarcoma
1
1991
86
0.110
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2009
77
0.110
 Why?
Phosphorylation
3
2009
1095
0.110
 Why?
Drug Monitoring
1
2012
114
0.110
 Why?
Gene Transfer Techniques
1
2011
148
0.110
 Why?
Magnetic Resonance Imaging
4
2014
3069
0.100
 Why?
Up-Regulation
2
2004
691
0.100
 Why?
Extracorporeal Membrane Oxygenation
1
2012
123
0.100
 Why?
Polymerase Chain Reaction
2
2009
921
0.100
 Why?
Blotting, Western
2
2009
777
0.100
 Why?
Sarcoma, Clear Cell
1
2009
3
0.100
 Why?
Glioblastoma
1
2012
226
0.100
 Why?
Species Specificity
1
2011
677
0.100
 Why?
Cell Transformation, Neoplastic
1
2012
402
0.100
 Why?
Drug Resistance, Neoplasm
2
2004
559
0.100
 Why?
Kidney
4
2016
1169
0.100
 Why?
Blood Vessels
1
2009
94
0.090
 Why?
Disseminated Intravascular Coagulation
1
2009
28
0.090
 Why?
Hamartoma
1
2009
31
0.090
 Why?
Gene Expression Profiling
2
2012
1322
0.090
 Why?
Adolescent
5
2018
8657
0.090
 Why?
Disease Progression
3
2015
1424
0.090
 Why?
Immunoprecipitation
1
2009
132
0.090
 Why?
Hematopoietic Stem Cell Transplantation
1
2015
818
0.090
 Why?
Dose-Response Relationship, Drug
2
2003
1969
0.090
 Why?
Down-Regulation
2
2015
501
0.090
 Why?
Mammary Neoplasms, Animal
1
2008
53
0.090
 Why?
Proto-Oncogene Proteins c-sis
2
2006
24
0.080
 Why?
Receptor, Platelet-Derived Growth Factor beta
2
2006
27
0.080
 Why?
Quality of Life
1
2015
1344
0.080
 Why?
Practice Guidelines as Topic
1
2015
1030
0.080
 Why?
Rhabdomyosarcoma
1
2007
43
0.080
 Why?
Sacrum
1
2007
27
0.080
 Why?
Spinal Neoplasms
1
2007
51
0.080
 Why?
Vaginal Neoplasms
1
2007
83
0.080
 Why?
Drug Administration Schedule
2
2016
931
0.080
 Why?
Liver Diseases
1
2009
224
0.080
 Why?
Transfection
1
2009
892
0.080
 Why?
RNA-Binding Proteins
2
2018
221
0.080
 Why?
Lectins
2
2004
82
0.080
 Why?
Cyclooxygenase 2 Inhibitors
1
2006
35
0.080
 Why?
Sacrococcygeal Region
1
2006
10
0.080
 Why?
Retrospective Studies
5
2018
7388
0.080
 Why?
Teratoma
1
2006
42
0.070
 Why?
Ultrasonography
3
2014
648
0.070
 Why?
Endothelial Cells
2
2008
385
0.070
 Why?
Loss of Heterozygosity
1
2005
84
0.070
 Why?
Chromosomes, Human
1
2005
64
0.070
 Why?
Cell Proliferation
2
2018
1541
0.070
 Why?
United States
2
2015
6050
0.070
 Why?
Muscle, Smooth
2
2003
358
0.070
 Why?
Pyrazoles
1
2006
149
0.070
 Why?
Angiopoietins
1
2004
6
0.070
 Why?
Sesquiterpenes
1
2004
12
0.070
 Why?
Proto-Oncogene Proteins
1
2008
642
0.070
 Why?
Ephrin-B2
1
2004
4
0.070
 Why?
Pregnancy Proteins
1
2004
38
0.070
 Why?
Genes, erbB-2
1
2003
24
0.070
 Why?
Lymphatic System
1
2004
51
0.070
 Why?
Sulfonamides
1
2006
295
0.060
 Why?
Polyethylene Glycols
2
2020
359
0.060
 Why?
Tomography, X-Ray Computed
1
2014
2439
0.060
 Why?
Thalidomide
1
2003
51
0.060
 Why?
Fluorescein Angiography
1
2004
89
0.060
 Why?
Hypoxia-Inducible Factor 1
1
2003
40
0.060
 Why?
Models, Animal
2
2001
248
0.060
 Why?
Necrosis
1
2003
190
0.060
 Why?
Blood Platelets
1
2003
148
0.060
 Why?
Perfusion
1
2003
184
0.060
 Why?
Liver Neoplasms, Experimental
1
2002
25
0.060
 Why?
Microscopy, Confocal
1
2003
269
0.060
 Why?
Thrombospondin 1
1
2002
21
0.060
 Why?
Male
9
2018
39429
0.060
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2003
147
0.060
 Why?
Wound Healing
2
2016
334
0.060
 Why?
Survival Rate
2
2008
1809
0.060
 Why?
Mice, Inbred C57BL
3
2015
3054
0.060
 Why?
Cells, Cultured
3
2015
2790
0.060
 Why?
Injections, Intraperitoneal
1
2001
101
0.050
 Why?
Breast Neoplasms
1
2015
2699
0.050
 Why?
Collagen
2
2016
262
0.050
 Why?
Epigenesis, Genetic
1
2005
430
0.050
 Why?
Drug Therapy, Combination
1
2004
904
0.050
 Why?
Biopsy
2
2016
1117
0.050
 Why?
Biopsy, Needle
1
2001
233
0.050
 Why?
Blood Volume Determination
1
2020
13
0.050
 Why?
Photoacoustic Techniques
1
2020
7
0.050
 Why?
Time Factors
3
2012
5144
0.050
 Why?
Neoplasm Staging
3
2013
1858
0.050
 Why?
Fibroblasts
2
2015
695
0.050
 Why?
Models, Biological
2
2008
1724
0.050
 Why?
Infectious Disease Transmission, Patient-to-Professional
1
2020
29
0.050
 Why?
Gene Expression
3
2009
1279
0.050
 Why?
Actins
1
2003
429
0.050
 Why?
Reference Values
1
2001
653
0.050
 Why?
Capillary Permeability
1
2020
128
0.050
 Why?
Growth Inhibitors
1
1999
42
0.050
 Why?
Mice, Transgenic
2
2015
1509
0.050
 Why?
Anaplasia
1
1998
5
0.050
 Why?
Cross Infection
1
2020
129
0.050
 Why?
Mice, Inbred Strains
1
1999
310
0.050
 Why?
Drug Delivery Systems
1
2020
172
0.050
 Why?
Magnetic Resonance Angiography
1
2001
248
0.050
 Why?
Feasibility Studies
1
2020
720
0.040
 Why?
Peritoneal Neoplasms
2
2013
146
0.040
 Why?
Gene Silencing
1
2018
163
0.040
 Why?
RNA, Messenger
2
2015
1920
0.040
 Why?
Klippel-Trenaunay-Weber Syndrome
1
2016
5
0.040
 Why?
Fetal Therapies
1
2016
5
0.040
 Why?
Mice, Inbred BALB C
2
2015
1038
0.040
 Why?
Head and Neck Neoplasms
1
2004
997
0.040
 Why?
Sensitivity and Specificity
1
2001
1938
0.040
 Why?
Health Care Costs
1
2018
225
0.040
 Why?
Intestine, Small
1
2018
291
0.040
 Why?
Lens, Crystalline
1
1997
65
0.040
 Why?
Pregnancy
2
2016
2671
0.040
 Why?
Rats, Wistar
1
2016
293
0.040
 Why?
Prenatal Diagnosis
1
2016
100
0.040
 Why?
Collagen Type VII
1
2015
3
0.040
 Why?
Clinical Protocols
1
2016
154
0.040
 Why?
Severity of Illness Index
1
2001
1686
0.040
 Why?
Myeloablative Agonists
1
2015
34
0.040
 Why?
Busulfan
1
2015
38
0.040
 Why?
Proto-Oncogene Proteins c-akt
2
2008
305
0.040
 Why?
Cytokines
1
1999
744
0.040
 Why?
Young Adult
2
2018
5702
0.040
 Why?
Octamer Transcription Factor-3
1
2015
14
0.040
 Why?
Length of Stay
1
2018
647
0.040
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2015
24
0.040
 Why?
Vidarabine
1
2015
140
0.030
 Why?
Vesicular Transport Proteins
1
2015
63
0.030
 Why?
p120 GTPase Activating Protein
1
2014
1
0.030
 Why?
Pandemics
1
2020
557
0.030
 Why?
Angiography
2
2006
200
0.030
 Why?
Cadherins
1
2015
143
0.030
 Why?
Follow-Up Studies
1
2001
3553
0.030
 Why?
Rupture, Spontaneous
1
2013
38
0.030
 Why?
Computer Systems
1
2013
81
0.030
 Why?
Mutation
2
2015
3745
0.030
 Why?
Infusions, Intravenous
2
2008
433
0.030
 Why?
Hospitalization
1
2018
749
0.030
 Why?
Tumor Suppressor Proteins
1
2015
273
0.030
 Why?
Antigens, CD
1
2015
466
0.030
 Why?
Transplantation, Homologous
1
2015
972
0.030
 Why?
Neoplasm, Residual
1
2013
141
0.030
 Why?
Membrane Glycoproteins
1
2015
419
0.030
 Why?
Aging
1
1997
624
0.030
 Why?
Fetal Diseases
1
2012
78
0.030
 Why?
Growth Substances
1
1992
79
0.030
 Why?
Tendons
1
1992
42
0.030
 Why?
Mesenchymal Stem Cells
1
2015
280
0.030
 Why?
Tendon Injuries
1
1992
34
0.030
 Why?
Plant Lectins
1
2012
12
0.030
 Why?
Blood Volume
1
2012
51
0.030
 Why?
Oxyhemoglobins
1
2012
31
0.030
 Why?
Cardiomegaly
1
2012
110
0.030
 Why?
Genes, Regulator
1
2012
65
0.030
 Why?
Chi-Square Distribution
1
2013
359
0.030
 Why?
Sarcoma, Experimental
1
1991
52
0.030
 Why?
von Willebrand Factor
1
1991
36
0.030
 Why?
L-Lactate Dehydrogenase
1
1991
67
0.030
 Why?
Fibroma
1
1991
30
0.030
 Why?
Lymphatic Metastasis
1
2013
465
0.030
 Why?
Hemoglobins
1
2012
172
0.030
 Why?
Intestinal Mucosa
1
2016
794
0.030
 Why?
Epithelial Cells
1
2015
619
0.030
 Why?
Oligonucleotides
1
1991
90
0.030
 Why?
Plasmids
1
2011
282
0.030
 Why?
Reproducibility of Results
2
2013
2571
0.030
 Why?
Homeodomain Proteins
1
2015
525
0.030
 Why?
Odds Ratio
1
2013
647
0.030
 Why?
Databases, Genetic
1
2012
251
0.030
 Why?
Regression Analysis
1
2012
588
0.030
 Why?
Fluorescent Dyes
1
2012
241
0.030
 Why?
Risk Factors
2
2013
5100
0.020
 Why?
Immunosuppressive Agents
1
2015
978
0.020
 Why?
Analysis of Variance
1
2012
899
0.020
 Why?
Proto-Oncogene Proteins c-kit
1
2009
79
0.020
 Why?
Logistic Models
1
2013
1113
0.020
 Why?
Recurrence
1
2012
1105
0.020
 Why?
DNA
2
2011
1246
0.020
 Why?
Fibroblast Growth Factor 4
1
2008
6
0.020
 Why?
Umbilical Veins
1
2008
45
0.020
 Why?
Glucuronidase
1
2008
20
0.020
 Why?
Heparan Sulfate Proteoglycans
1
2008
19
0.020
 Why?
Half-Life
1
2008
98
0.020
 Why?
Survival Analysis
1
2012
1519
0.020
 Why?
Immunoenzyme Techniques
1
2008
301
0.020
 Why?
Calcium-Binding Proteins
1
2008
111
0.020
 Why?
Mice, Inbred C3H
1
2008
379
0.020
 Why?
Pancreatic Neoplasms
1
2013
597
0.020
 Why?
Base Sequence
1
1991
2323
0.020
 Why?
Maximum Tolerated Dose
1
2008
258
0.020
 Why?
Area Under Curve
1
2008
334
0.020
 Why?
Molecular Sequence Data
1
1991
3050
0.020
 Why?
Enzyme Activation
1
2008
691
0.020
 Why?
Iliac Artery
1
2006
34
0.020
 Why?
Receptors, CXCR4
1
2006
39
0.020
 Why?
DNA Fingerprinting
1
2005
16
0.020
 Why?
Remission Induction
1
2008
701
0.020
 Why?
WT1 Proteins
1
2005
18
0.020
 Why?
Risk Assessment
1
2013
2158
0.020
 Why?
Insulin-Like Growth Factor II
1
2005
33
0.020
 Why?
Blotting, Southern
1
2005
131
0.020
 Why?
Blotting, Northern
1
2005
256
0.020
 Why?
RNA, Untranslated
1
2005
61
0.020
 Why?
Skin
1
2008
538
0.020
 Why?
Cyclohexanes
1
2004
9
0.020
 Why?
Nitroimidazoles
1
2004
7
0.020
 Why?
Fluorescein
1
2004
17
0.020
 Why?
Prognosis
1
2012
3522
0.020
 Why?
Embolization, Therapeutic
1
2006
203
0.020
 Why?
Microcirculation
1
2004
102
0.020
 Why?
Catheter Ablation
1
2006
213
0.020
 Why?
Radiation-Sensitizing Agents
1
2004
95
0.020
 Why?
Protein Binding
1
2008
1447
0.020
 Why?
Antibiotics, Antineoplastic
1
2004
108
0.020
 Why?
Heart Defects, Congenital
1
2006
336
0.020
 Why?
Antibody Specificity
1
2003
133
0.020
 Why?
Genome
1
2005
338
0.010
 Why?
Topoisomerase I Inhibitors
1
2002
35
0.010
 Why?
Adult
3
2009
24528
0.010
 Why?
DNA Methylation
1
2005
570
0.010
 Why?
Carcinoma, Lewis Lung
1
1999
22
0.010
 Why?
Tissue Distribution
1
1999
277
0.010
 Why?
Cattle
1
1999
370
0.010
 Why?
Clinical Trials as Topic
1
2004
1149
0.010
 Why?
Neovascularization, Physiologic
1
1999
131
0.010
 Why?
Enzyme Inhibitors
1
2002
626
0.010
 Why?
Liver Transplantation
1
2006
1238
0.010
 Why?
Scattering, Radiation
1
1997
113
0.010
 Why?
Recombinant Proteins
1
1999
1015
0.010
 Why?
Factor Analysis, Statistical
1
1997
100
0.010
 Why?
Polymorphism, Single Nucleotide
1
2005
2254
0.010
 Why?
Cataract
1
1997
76
0.010
 Why?
Light
1
1997
275
0.010
 Why?
3T3 Cells
1
1992
94
0.010
 Why?
Dogs
1
1992
694
0.010
 Why?
Middle Aged
1
1997
23951
0.000
 Why?
Kandel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (400) concept(s)
_
Co-Authors Expand Description
See all (13) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_